OPF-310 / Otsuka - LARVOL DELTA

A Study to Investigate Safety and Effectiveness of Pancreatic Cells Derived from Pigs (OPF-310) in Patients with Type 1 Diabetes Mellitus (clinicaltrials.gov) - P1/2 | N=13 | Recruiting | Sponsor: Otsuka Pharmaceutical Factory, Inc. | Not yet recruiting ➔ Recruiting | Initiation date: Dec 2024 ➔ Apr 2025

Enrollment open • Trial initiation date • Diabetes • Hypoglycemia • Metabolic Disorders • Transplantation • Type 1 Diabetes Mellitus